Evidence map›Paper›PMID 25146013›Full record

ArticleJournal of endodontics2014

Biologic activity of porphyromonas endodontalis complex lipids.

Christopher S Mirucki, Mehran Abedi, Jin Jiang, Qiang Zhu, Yu-Hsiung Wang, Kamran E Safavi, Robert B Clark, Frank C Nichols

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of endodontics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Lipopolysaccharide fromInternational journal of molecular sciences · 2022
    Article
  3. Article
  4. Novel Glycerophospholipid, Lipo- andMolecules (Basel, Switzerland) · 2021
    Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Christopher S MiruckiDivision of Endodontology, Department of Oral Health and Diagnostic Sciences, School of Dental Medicine, University of Connecticut Health Center, Farmington, Connecticut.
Mehran AbediDivision of Endodontology, Department of Oral Health and Diagnostic Sciences, School of Dental Medicine, University of Connecticut Health Center, Farmington, Connecticut.
Jin JiangDivision of Endodontology, Department of Oral Health and Diagnostic Sciences, School of Dental Medicine, University of Connecticut Health Center, Farmington, Connecticut.
Qiang ZhuDivision of Endodontology, Department of Oral Health and Diagnostic Sciences, School of Dental Medicine, University of Connecticut Health Center, Farmington, Connecticut.
Yu-Hsiung WangDivision of Pediatric Dentistry, Department of Craniofacial Sciences, School of Dental Medicine, University of Connecticut Health Center, Farmington, Connecticut.
Kamran E SafaviDivision of Endodontology, Department of Oral Health and Diagnostic Sciences, School of Dental Medicine, University of Connecticut Health Center, Farmington, Connecticut.
Robert B ClarkDepartment of Immunology, University of Connecticut School of Medicine, University of Connecticut Health Center, Farmington, Connecticut.
Frank C NicholsDivision of Periodontology, Department of Oral Health and Diagnostic Sciences, School of Dental Medicine, University of Connecticut Health Center, Farmington, Connecticut. Electronic address: Nichols@nso.uchc.edu.
UConn Health · US

Funding

Porphyromonas gingivalis lipids mediate bone loss through TLR2R01DE021055 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI NICHOLS, FRANK C · 2011 to 2015
$1.9M
NIDCR NIH HHS R01 DE021055NIDCR NIH HHS R01 DE021055-01A1
6 · The paper itself

Abstract

introductionPeriapical infections secondary to pulpal necrosis are associated with bacterial contamination of the pulp. Porphyromonas endodontalis, a gram-negative organism, is considered to be a pulpal pathogen. P. gingivalis is phylogenetically related to P. endodontalis and synthesizes several classes of novel complex lipids that possess biological activity, including the capacity to promote osteoclastogenesis and osteoclast activation. The purpose of this study was to extract and characterize constituent lipids of P. endodontalis and evaluate their capacity to promote proinflammatory secretory responses in the macrophage cell line, RAW 264.7, as well as their capacity to promote osteoclastogenesis and inhibit osteoblast activity.

methodsConstituent lipids of both organisms were fractionated by high-performance liquid chromatography and were structurally characterized using electrospray mass spectrometry or electrospray-mass spectrometry/mass spectrometry. The virulence potential of P. endodontalis lipids was then compared with known biologically active lipids isolated from P. gingivalis.

resultsP. endodontalis total lipids were shown to promote tumor necrosis factor alpha secretion from RAW 264.7 cells, and the serine lipid fraction appeared to account for the majority of this effect. P. endodontalis lipid preparations also increased osteoclast formation from RAW 264.7 cells, but osteoblast differentiation in culture was inhibited and appeared to be dependent on Toll-like receptor 2 expression.

conclusionsThese effects underscore the importance of P. endodontalis lipids in promoting inflammatory and bone cell activation processes that could lead to periapical pathology.

Indexed as

AnimalsCell DifferentiationCell LineCells, CulturedCeramidesChromatography, High Pressure LiquidFemaleInflammation MediatorsLipidsMacrophagesMiceMice, Inbred C57BLMice, KnockoutOsteoblastsOsteoclastsPhosphatidylethanolaminesceramide phosphoethanolamineCeramidesdihydroceramideInflammation MediatorsLipidsphosphatidylethanolaminePhosphatidylethanolaminesSerineSphingomyelinsTlr2 protein, mouseToll-Like Receptor 2Tumor Necrosis Factor-alphaVirulence FactorsElectrospray mass spectrometryosteoblastosteoclastogenesisPorphyromonas endodontalisRAW 264.7 cells

Identifiers

PMID25146013
PMCPMC4143668
OpenAlexW2074007773

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.